About Us
Our Mission
Company Profile
Executive Team
Board of Directors
Scientific Advisory Board
ProTcellᵀᴹ platform
Pipeline
News & Partnering
News & Press Releases
Events & Presentations
Partnering
Contact
News & Press Releases
All
News & Press Releases
All
Events & Presentations
Smart Immune Announces Oral Presentation of Cell Fate Plasticity Data of its T-cell Progenitor-Based Therapy Platform (ProTcell™) at ASGCT 2022
May 20, 2022
Smart Immune Wins Best Therapeutic Innovation and Oncology Upward Investmeant Awards at MATWIN
May 19, 2022
Deep molecular characterization of ex vivo generated T cell progenitors open perspectives for the development of new therapies
May 3, 2022
Smart Immune Announces Research Collaboration with Memorial Sloan Kettering Cancer Center (MSKCC) to Expedite Development of a Next Generation CAR-T Through its Long Lasting, Exhaustion-Free CAR ProTcell™ Platform
December 9, 2021
Smart Immune Announces Acceptance of Two Abstracts Covering Preclinical Research and Clinical Data at the American Society of Hematology
November 5, 2021
Smart Immune Receives IRB Approval For Phase 1/2 Clinical Trial of Proprietary Allogeneic T-cell Product Smart-101 (ProTcell™) for AML and ALL.
October 13, 2021
Next
→